Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
SciSparc Ltd. - Ordinary Shares
(NQ:
SPRC
)
1.450
-0.010 (-0.68%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about SciSparc Ltd. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Nasdaq Falls Over 100 Points; General Mills Earnings Top Views
↗
September 17, 2025
Via
Benzinga
Why SciSparc (SPRC) Stock Is Skyrocketing Today
↗
September 17, 2025
SciSparc shares are trading sharply higher Wednesday morning. AutoMax Motors filed a motion with the Jerusalem District Court in connection with its merger with the company.
Via
Benzinga
Dow Surges 250 Points; US Housing Starts Tumble In August
↗
September 17, 2025
Via
Benzinga
Topics
Stocks
Discover the top movers in Wednesday's pre-market session.
↗
September 17, 2025
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 17, 2025
Via
Benzinga
Stock Market Today: S&P 500, Nasdaq Futures Dip Ahead Of FOMC Decision On Interest Rates—General Mills, New Fortress, Cracker Barrel In Focus
↗
September 17, 2025
U.S. stock futures were swinging on Wednesday following Tuesday's negative moves. Futures of major benchmark indices were mixed.
Via
Benzinga
Topics
Stocks
Why New Fortress Energy Shares Are Trading Higher By 41%; Here Are 20 Stocks Moving Premarket
↗
September 17, 2025
Via
Benzinga
SciSparc Stock Shoots Up Over 89% After Hours: What's Going On?
↗
September 16, 2025
SciSparc's stock surged 89.13% to $3.48 after-hours on news of a court-granted stay in its merger with AutoMax, though the stock remains down 71.87% over the past year.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 16, 2025
Via
Benzinga
What's going on in today's after hours session
↗
September 16, 2025
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 09, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
August 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
August 28, 2025
Via
Benzinga
SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc
August 28, 2025
From
SciSparc Ltd
Via
GlobeNewswire
Wondering what's happening in today's pre-market session?
↗
August 28, 2025
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel
August 28, 2025
From
SciSparc Ltd
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
August 22, 2025
Via
Benzinga
SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
August 07, 2025
From
SciSparc Ltd
Via
GlobeNewswire
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
August 07, 2025
From
Clearmind Medicine Inc.
Via
GlobeNewswire
SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC
July 30, 2025
From
SciSparc Ltd
Via
GlobeNewswire
Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
July 30, 2025
From
Clearmind Medicine Inc.
Via
GlobeNewswire
SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
July 30, 2025
From
SciSparc Ltd
Via
GlobeNewswire
SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification
July 22, 2025
From
SciSparc Ltd
Via
GlobeNewswire
SciSparc Announces 1-for-21 Reverse Share Split
June 24, 2025
Following the reverse share split, the Company will have approximately 534,600 outstanding shares, out of which approximately 516,727 will be publicly held
From
SciSparc Ltd
Via
GlobeNewswire
SciSparc Announces Publication of Japanese Patent Application
May 27, 2025
From
SciSparc Ltd
Via
GlobeNewswire
Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction
May 12, 2025
From
Clearmind Medicine Inc.
Via
GlobeNewswire
SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction
May 12, 2025
From
SciSparc Ltd
Via
GlobeNewswire
Stocks Under $1 To Watch: $NITO, $SPRC, $PNPNF, $NCNA, $PRSO – Multi-Sectors Momentum Building more inside…
May 05, 2025
Via
AB Newswire
Topics
Intellectual Property
Monday's session: top gainers and losers
↗
May 05, 2025
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
